BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 12379888)

  • 21. High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation.
    MacMillan ML; Radloff GA; Kiffmeyer WR; DeFor TE; Weisdorf DJ; Davies SM
    Transplantation; 2003 Dec; 76(12):1758-62. PubMed ID: 14688528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
    Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
    Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation.
    Keever CA; Leong N; Cunningham I; Copelan EA; Avalos BR; Klein J; Kapoor N; Adams PW; Orosz CG; Tutschka PJ
    Bone Marrow Transplant; 1994 Jul; 14(1):137-45. PubMed ID: 7951101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
    Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The incidence of DPB1 differences between serological and mixed lymphocyte culture matched unrelated individuals: implications for selection of bone marrow donors.
    Eiermann TH; Fakler J; Goldmann SF
    Bone Marrow Transplant; 1992 Mar; 9(3):157-60. PubMed ID: 1387332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.
    Kamei H; Oike F; Fujimoto Y; Yamamoto H; Tanaka K; Kiuchi T
    Liver Transpl; 2006 Jan; 12(1):140-5. PubMed ID: 16382466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical importance of HLA-DPB1 in haematopoietic cell transplantation.
    Shaw BE; Gooley T; Madrigal JA; Malkki M; Marsh SG; Petersdorf EW
    Tissue Antigens; 2007 Apr; 69 Suppl 1():36-41. PubMed ID: 17445160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.
    Morishima Y; Kashiwase K; Matsuo K; Azuma F; Morishima S; Onizuka M; Yabe T; Murata M; Doki N; Eto T; Mori T; Miyamura K; Sao H; Ichinohe T; Saji H; Kato S; Atsuta Y; Kawa K; Kodera Y; Sasazuki T;
    Blood; 2015 Feb; 125(7):1189-97. PubMed ID: 25519752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.
    Greinix HT; Faé I; Schneider B; Rosenmayr A; Mitterschiffthaler A; Pelzmann B; Kalhs P; Lechner K; Mayr WR; Fischer GF
    Bone Marrow Transplant; 2005 Jan; 35(1):57-62. PubMed ID: 15531903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation.
    Shaw BE; Gooley TA; Malkki M; Madrigal JA; Begovich AB; Horowitz MM; Gratwohl A; Ringdén O; Marsh SG; Petersdorf EW
    Blood; 2007 Dec; 110(13):4560-6. PubMed ID: 17726164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor-recipient pairs.
    Hurley CK; Baxter-Lowe LA; Begovich AB; Fernandez-Vina M; Noreen H; Schmeckpeper B; Awdeh Z; Chopek M; Salazar M; Williams TM; Yunis EJ; Kitajima D; Shipp K; Splett J; Winden T; Kollman C; Johnson D; Ng J; Hartzman RJ; Hegland J
    Bone Marrow Transplant; 2000 Feb; 25(4):385-93. PubMed ID: 10723581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.
    Moyer AM; Hashmi SK; Kroning CM; Kremers WK; De Goey SR; Patnaik M; Litzow M; Gastineau DA; Hogan WJ; Jacob EK; Kreuter JD; Wakefield LL; Gandhi MJ
    Eur J Haematol; 2017 Sep; 99(3):275-282. PubMed ID: 28632323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors.
    Martin PJ
    Bone Marrow Transplant; 1991 Sep; 8(3):217-23. PubMed ID: 1958902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Less acute GVHD in patients receiving totally matched transplants from unrelated donors.
    Lönnqvist B; Ljungman P; Norrby M; Olerup O; Ringdén O; Winiarski J
    Transplant Proc; 1995 Dec; 27(6):3528-9. PubMed ID: 8540084
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
    J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
    Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
    Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation.
    Eisner MD; August CS
    Bone Marrow Transplant; 1995 May; 15(5):663-8. PubMed ID: 7670393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolated HLA-C mismatches in unrelated donor transplantation for CML.
    Tiercy JM; Passweg J; van Biezen A; Zander A; Kröger N; Gratwohl A; Chapuis B; Helg C; Brinch L; Cornelissen J; Oudshoorn M; Ruutu T; Volin L; Niederwieser D; Roosnek E;
    Bone Marrow Transplant; 2004 Aug; 34(3):249-55. PubMed ID: 15195077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.